One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Contents
doi : 10.1016/S0161-6420(22)00944-7
Volume 130, Issue 2, February 2023, Pages A5, A6, A8, A10, A12
This Issue at a Glance
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2022.11.020
Volume 130, Issue 2, February 2023, Page 123
A Simple Vista en Este Número
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2022.11.019
Volume 130, Issue 2, February 2023, Pages e1-e2
期刊一览
Sandeep Ravindran, PhD
doi : 10.1016/j.ophtha.2022.11.022
Volume 130, Issue 2, February 2023, Page e3
Inappropriate Use of the Term “Papilledema� in the Medical Literature: A Systematic Review of Case Reports across Specialties
Brendan Tao, BHSc,1 Amir Vosoughi, MD,2 Edward Margolin, MD,3,4,7 Jonathan A. Micieli, MD, CM
doi : 10.1016/j.ophtha.2022.09.017
Volume 130, Issue 2, February 2023, Pages 129-136
Papilledema: An Inaccurate Term in Our Medical Vocabulary
Don Minckler, MS, MD - Encinitas, California Ken Lin, MD, PhD - Irvine, California
doi : 10.1016/j.ophtha.2022.12.009
Volume 130, Issue 2, February 2023, Pages 137-138
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
Gus Gazzard, FRCOphth,1,2 Evgenia Konstantakopoulou, PhD,1,2,3 David Garway-Heath, MD,1,2 Mariam Adeleke, PhD,4,5 Victoria Vickerstaff, PhD,6,7 Gareth Ambler, PhD,4 Rachael Hunter, MSc,5 Catey Bunce, DSc, 8,9 Neil Nathwani, BSc,1,2 Keith Barton, FRCS,1,2 on behalf of the LiGHT Trial Study Group
doi : 10.1016/j.ophtha.2022.09.009
Volume 130, Issue 2, February 2023, Pages 139-151
Severe Unilateral Vision Loss in a 77-Year-Old Man
VICTORIA S ATTAROVA , MD, MS C 1 MICHAEL S. LEE , MD 1 ANNE S. ABEL , MD 1
doi : 10.1016/j.ophtha.2022.03.016
Volume 130, Issue 2, February 2023, Page 151
The Effect of Macular Hole Duration on Surgical Outcomes: An Individual Participant Data Study of Randomized Controlled Trials
Declan C. Murphy, MBBS, MRes, 1 Mo Al-Zubaidy, MBBS, MRes, 1 Noemi Lois, PhD,2 Neil Scott, MSc, PhD,3 David H. Steel, MBBS, MD,1,4 for the Macular Hole Duration Study Group
doi : 10.1016/j.ophtha.2022.08.028
Volume 130, Issue 2, February 2023, Pages 152-163
Multivariable Analyses of Amblyopia Treatment Outcomes from a Clinical Data Registry
Michael X. Repka, MD, MBA,1 Charles Li, BA, 2 Flora Lum, MD
doi : 10.1016/j.ophtha.2022.09.005
Volume 130, Issue 2, February 2023, Pages 164-166
Progression of Polypoidal Lesions Associated with Exudative Recurrence in Polypoidal Choroidal Vasculopathy
Qiyu Bo, MD,1,2, * Min Zhang, MD,1,2, * Jieqiong Chen, MD,1,2,3 Huixun Jia, MD,1,2 Mengxi Shen, MD,6 Mengsha Sun, MD,1,2 Mengqiao Xu, MD,1,2 Jingyang Feng, MD,1,2 Quan Yan, MD,1,2 Yang Yu, BS, 1,2 Peirong Huang, MD,1,2 Tong Li, MD,1,2,3 Fenghua Wang, MD, 1,2,3,4,5 Philip J. Rosenfeld, MD, PhD,6 Xiaodong Sun, MD, PhD
doi : 10.1016/j.ophtha.2022.09.013
Volume 130, Issue 2, February 2023, Pages 167-178
Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis
Rohan Bir Singh, MD,1,2,3 Uday Pratap Singh Parmar, BS, 4 Francesca Kahale, MD,1 Aniruddha Agarwal, MD,5,6 Edmund Tsui, MD
doi : 10.1016/j.ophtha.2022.08.027
Volume 130, Issue 2, February 2023, Pages 179-186
Tarsal Fibroma of the Eyelid
AARON R. K AUFMAN , MD DANIEL K. L EE , MD ANN Q. TRAN , MD
doi : 10.1016/j.ophtha.2022.06.005
Volume 130, Issue 2, February 2023, Page 186
Long-term Alcohol Consumption and Risk of Exfoliation Glaucoma or Glaucoma Suspect Status among United States Health Professionals
Akiko Hanyuda, MD, MPH,1,2 Bernard A. Rosner, PhD, 3,4 Janey L. Wiggs, MD, PhD,5 Kazuno Negishi, MD, PhD, 1 Louis R. Pasquale, MD,6, * Jae H. Kang, ScD
doi : 10.1016/j.ophtha.2022.08.023
Volume 130, Issue 2, February 2023, Pages 187-197
Self-limiting Bilateral Foveal Detachment after Coup-Contrecoup Injury
HAOXING D. J IN , MD JONATHAN F. R USSELL , MD, P H D
doi : 10.1016/j.ophtha.2022.05.022
Volume 130, Issue 2, February 2023, Page 197
Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial
Jing Dong, MD,1, * Zhuoting Zhu, MD, PhD,2,3, * Haifeng Xu, MD,4, * Mingguang He, MD, PhD
doi : 10.1016/j.ophtha.2022.08.024
Volume 130, Issue 2, February 2023, Pages 198-204
Optic Nerve Sheath Calcification
DANIELLE R. I SEN , DO 1 SIDDHARTHA G ADDAMANUGU , MD 2 LANNING B. KLINE , MD
doi : 10.1016/j.ophtha.2022.03.013
Volume 130, Issue 2, February 2023, Page 204
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy: Longitudinal Evaluation in Age-Related Macular Degeneration
Zhichao Wu, BAppSc(Optom), PhD,1,2 Kai Lyn Goh, BOptom, 1,2 Lauren A.B. Hodgson, MPH,1 Robyn H. Guymer, MBBS, PhD
doi : 10.1016/j.ophtha.2022.09.004
Volume 130, Issue 2, February 2023, Pages 205-212
Training Deep Learning Models to Work on Multiple Devices by Cross-Domain Learning with No Additional Annotations
Yue Wu, PhD,1 Abraham Olvera-Barrios, MD,2,3 Ryan Yanagihara, MD,1 Timothy-Paul H. Kung, MD,1 Randy Lu, BS, 1 Irene Leung, BA (Hons),2 Amit V. Mishra, MD,2 Hanan Nussinovitch, MD,2 Gabriela Grimaldi, MD,2 Marian Blazes, MD,1 Cecilia S. Lee, MD, MS, 1,4 Catherine Egan, FRANZCO, 2,3 Adnan Tufail, FRCOphth, 2,3 Aaron Y. Lee, MD, MSCI
doi : 10.1016/j.ophtha.2022.09.014
Volume 130, Issue 2, February 2023, Pages 213-222
Squamous Cell Papilloma of the Conjunctiva
LIPING W ANG , MD 1 GUOPING W ANG , MD
doi : 10.1016/j.ophtha.2022.05.023
Volume 130, Issue 2, February 2023, Page 222
Women’s Representation among Lead Investigators of Clinical Trials in Ophthalmology
MAYLANDER M ENARD , MHS 1 XIANGYU J I, MS 2 QINGXIA CHEN , P H D2,3 JANICE C. L AW , MD 3 CAROLINE R. BAUMAL , MD 4 AVNI P. F INN , MD, MBA
doi : 10.1016/j.ophtha.2022.10.025
Volume 130, Issue 2, February 2023, Pages 223-225
Re: Lee et al.: The association among blood pressure, blood pressure medications, and glaucoma in a nationwide electronic health records database (Ophthalmology. 2022;129:276–284.)
G UANGSEN LIU , MD
doi : 10.1016/j.ophtha.2022.10.009
Volume 130, Issue 2, February 2023, Page e5
Reply
SOPHIA Y. W ANG , MD, MS W ENDENG H U, MS K ULDEV S INGH , MD, MPH
doi : 10.1016/j.ophtha.2022.10.010
Volume 130, Issue 2, February 2023, Pages e5-e6
Re: Bartley et al.: Celebrating Pioneers: The First Board-Certified Women in American Medicine (Ophthalmology. 2022:129:737-741)
CHRISTOPHER T. LEFFLER , MD, MPH 1,2 GEORGE B. BARTLEY , MD 3,4 M EGHAN M C G OWAN , MS
doi : 10.1016/j.ophtha.2022.10.012
Volume 130, Issue 2, February 2023, Pages e6-e7
Re: Brodsky MC: The pseudo-hypoplastic myopic optic disc (Ophthalmology. 2022 Aug 13:S0161-6420(22)00487-0. doi: 10.1016/j.ophtha.2022.06.026. Online ahead of print)
ALEXANDER A. S HPAK , MD, P H D
doi : 10.1016/j.ophtha.2022.10.007
Volume 130, Issue 2, February 2023, Page e7
Reply
M ICHAEL C. B RODSKY , MD
doi : 10.1016/j.ophtha.2022.10.008
Volume 130, Issue 2, February 2023, Pages e7-e8
